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1. In~~d~~tion 
Acetylcholinesterase (AChE; EC 3.1.1.7) occurs in 
mammalian and avian skeletal muscle in a number of 
molecular forms as characterised by their sedimenta- 
tion coefficients on sucrose gradients. In rat diaphragm, 
three principal forms were observed by Hall ]I] , who 
showed that the heaviest (H) form, 16 S AChE, was 
specifically associated with the endplate regions of 
the muscle and was greatly reduced in amount upon 
denervation. Vigny et al. [2,3] provided additional 
evidence suggesting that the H form was endplate- 
specific in various muscles of the rat and the chicken. 
In all 3 studies, however, the H form accounted for 
only a minor part of the total AChE activity, the 
greater part of the enzyme occurring in peaks of 
medium ($4) or low (L) sedimentation coefficient. 
Treatment with collagenase orproteases can modify 
the molecular forms of AChE in skeletal muscle [4-6] , 
and it has been suggested that endogenous proteases 
may affect the distribution of AChE species observed 
in skeletal muscle xtracts [5,7] . In the present study, 
therefore, we have examined the effect of certain 
protease inhibitors on the sedimentation profile of 
AChE activity in extracts of various chicken muscles 
and of rat diaphragm. We will demonstrate hat use of 
protease inhibitors in the extraction medium prevents 
degradation of the intrinsic molecular forms of AChE 
and.greatly simplifies the sedimentation profiles 
obtained, Using an appropriate mature of ~hibitors, 
it is shown that AChE in normal pectoral muscle is 
predominantly of the H (19.5 S) type. In the pectoral 
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muscle of dystrophic hickens the major forms are 
the H form and an L (6.5 S) species. 
2. Materials and methods 
Acetylthiocholine iodide, 5 ,S’-dithiobis(2nitro- 
benzoic acid) (DNTB), beef liver catalase, EGTA, N- 
ethylmaleimide, benzamidine hydrochloride and 
bacitracin were obtained from Sigma Chemicals; tetra- 
isopropylpyrophosphoramide ( so-~MPA) from Koch- 
Light and Triton X-100 from Rohm and Haas. Pep 
statin and leupeptin were provided by the USA-Japan 
Cooperative Cancer Research Program, 
2.2.Frepffrution of muscle tissue extracts 
Tissue extracts were made from muscles of freshly 
sacrificed animals (normal (line 412) or dystrophic 
(line 413) chickens from the University of California 
(Davis) flock, or Sprague-Dawley rats). Samples 
(-100 mg) of the muscle were homogenised in 1 ml 
ice-cold extraction buffer in a glass-glass hand 
homogenizer. The homogenate was centrifuged at 
1.5 000 rev./min for 30 min in an SS-34 rotor in a 
Sorvall RC-5 centrifuge at 4”C, and the pellet 
discarded. The extraction media used were either the 
control medium, which was composed of 1% Triton 
X-100/1 M NaCl/O.Ol M phosphate, pH 7.0, or the 
~tiprotease medium which contained, in addition, 
10 mM EGTA, 2 mM benzamidine hydrochloride, 
5 mM N-ethylmaleimide, 40 pg/ml eupeptin and 
20 pg/ml pepstatin, and was prepared immediately 
before use. Where stated, bacitracin (1 mg/ml) was 
also included in the antiprotease medium. 
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2.3. Acetylcholinesterase assays 
AChE assays were performed by the method in 
[8] in a reaction medium containing 0.1 mM iso- 
OMPA/l mM DTNB/O.l% Triton X-100/0.1 M 
phosphate, pH 7.0. After preincubation at 25°C for 
30 min to permit full inactivation of pseudocholines- 
terase (acylcholine hydrolase; EC 3.1 .1.8) by the iso- 
OMPA [9], the reaction was initiated by addition of 
acetylthiocholine iodide to final 0.75 mM. 
2.4. Sucrose gradient centrifugation 
Centrifugation was performed on 5-20% sucrose 
gradients layered over a 60% sucrose cushion (0.5 ml) 
using 12 ml tubes in a SW40Ti rotor, at 40 000 rev./ 
min for 17 h in a Beckman L5-65 ultracentrifuge at 
4’C. The sucrose solutions were made up in 1 M NaCl/ 
0.1% Triton X-100/0.01 M phosphate, pH 7.0. Beef 
liver catalase (11.4 S) was the principal marker. 
3. Results 
3.1. Chicken muscles 
Sucrose gradient centrifugation of chicken skeletal 
muscle reveals AChE activity to be principally con- 
centrated in 3 zones of the gradient, arbitrarily 
designated as heavy (H, 15-20 S), medium (M, 
10-l 3 S) and light (L, 4-7 S). Figure la shows a 
typical gradient obtained with pectoral muscle from a 
day 29 dystrophic chicken extracted in 1% Triton/ 
1 M NaCl in the absence of protease inhibitors. It is 
known that in fast muscles of dystrophic chickens 
AChE levels are greatly elevated [lo] , and it has 
recently been shown that this elevation is largely 
accounted for by an increase in the L forms of the 
enzyme [ 111. Indeed it can be seen that there are 
considerable amounts of two light forms, Lr (~4.5 S) 
and Lz (-6.5 S), as well as of one heavy (HZ, -19 S) 
form. However, if extraction issimilarly performed at 
identical salt and detergent concentrations but in the 
presence of protease inhibitors (fig.1 b) the Hz and L-a 
components become much more pronounced and the 
Lr component is almost totally absent. The effect of 
the protease inhibitors is further emphasised if the 
corresponding extracts are incubated for 1 h at 38°C 
before application to the gradient. In the absence of 
protease inhibitors (fig.lc) the Ha and La forms are 
almost completely eliminated, over 40% activity 
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Fig.1. Sucrose gradient profiles of AChE activity in extracts 
of pectoral muscle of a day 29 dystrophic chicken, (a) 
Extraction in control medium. (b) Extraction in antiprotease 
medium. (c) Extraction in control medium followed by incu- 
bation for 1 hat 38°C. (d) Extraction in antiprotease medium 
followed by incubation for 1 h at 38°C. The arrows denote 
the position of the catalase marker. 
appears as large aggregates, the M forms are elevated 
and small amounts of Lr are observed. At 38’C, in 
the presence of protease inhibitors (fig.ld), although 
30% activity is still in the aggregates, the Ha peak 
is only slightly diminished, there is no increase in the 
M region and, while the La form is greatly reduced 
compared to an untreated sample, no concomitant 
appearance of Lr occurs. It should be emphasised that 
the incubation at 38’C produces no significant 
decrease in the overall AChE activity of either the 
control or antiprotease extracts. 
Figure 2a demonstrates that in young (day 7) 
normal chickens several molecular forms of AChE are 
also observed even in the presence of protease inhib- 
itors, the major components being Ha and M, with 
Hr (15.7 S) and L-r also present; Lr is almost entirely 
absent. If, however, an extract from a more mature 
(e.g., day 32) normal bird, made in the presence of 
167 
Volume 94, number 1 FEBS LETTERS 
1.0 
t 
a 
20.6 
0.6_ 
20 40 60 
FRACTIONS 
Fig.2. Sucrose gradient profiles of AChE activity in extracts 
of pectoral muscle of normal chickens. (a) Extract of day 7 
chicken in antiprotease medium including bacitracin. (b) 
Extract of day 32 chicken in antiprotease medium. (c) 
Extract of day 32 chicken in control medium. The arrows 
denote the position of the catalase marker. 
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protease inhibitors, is similarly analysed (fig2b), the 
Hz form is found to be predominant, L forms being 
present to only a minor extent and M forms almost 
completely absent. If such a muscle is similarly 
extracted without protease inhibitors, the Hz peak is 
greatly decreased in magnitude, and lighter forms 
account for a large part of the activity seen on the 
gradients (fig.2c). Prolonged storage of such homog- 
enates at -2O”C, or of frozen tissue prior to homog- 
enisation, further reduce the level of Hz while lighter 
forms become more prominent (not shown). 
Figure 3a shows that in the presence of protease 
inhibitors during extraction, another singly-innervated 
fast muscle, the posterior latissimus dorsi (PLD), also 
displays only one major AChE component, the Ha 
form, in normal adult chickens. This does not, how- 
ever, hold true for all skeletal muscles. The multiply- 
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Fig.3. Sucrose gradient profiles of AChE activity in extracts 
of PLD, ALD and cardiac muscles from normal chickens. (a) 
PLD from day 60 chicken in antiprotease medium containing 
bacitracin. (b) ALD from day 60 chicken in antiprotease 
medium containing bacitracin. (c) Cardiac muscle from day 32 
chicken in antiprotease medium. The arrows denote the posi- 
tion of the catalase marker. 
innervated slow muscle, the anterior latissimus dorsi 
(ALD), contains only minor amounts of the H and M 
forms, even when freshly homogenised in the presence 
of the protease inhibitors, the major species being the 
L (6.5 S) form (fig.3b). Cardiac muscle presents yet 
again a different pattern, almost all AChE activity 
being concentrated in the M region of the gradient 
(fig3c). 
3.2. Rat muscles 
The effects of protease inhibitors on the distribu- 
tion of molecular forms of AChE in skeletal muscle is 
not confined to the chicken. If sucrose gradient cen- 
trifugation is performed on extracts of the endplate 
regions of rat diaphragm made in the presence and 
absence of protease inhibitors, two very different 
patterns are obtained. In the absence of the inhibitors 
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Fig.4. Sucrose gradient profiles of AChE activity in extracts 
of endplate regions dissected from the diaphragms of month 6 
rats. (a) Extraction in antiprotease medium containing baci- 
tracin. (b) Extraction in control medium. The arrows denote 
the position of the catalase marker. 
the H (16 S) form is a minor component compared 
to the L and M species (iig.4b), whereas in their pres- 
ence it is the major form observed (figda). Inspection 
of figAa,b also reveals that in the presence of the 
protease inhibitors heavier components in both the M 
and L zones of the gradient predominate, whereas 
lighter forms are more prevalent in both zones in the 
absence of in~bitors. 
4. Discussion 
The results presented illustrate two principal 
points: 
1. 
2. 
The use of suitable protease inhibitors in the prep- 
aration of skeletal muscle extracts markedly 
retards the modification of intrinsic forms of AChE 
present in the tissue. 
Although multiple molecular forms of AChE are 
indeed found in muscle tissue, when a given muscle 
type from an adult is examined under conditions 
where degradation islargely prevented, the distri- 
bution of molecular forms is, in fact, much simpler 
than was thought previously, asingle molecular 
form frequently predominating. 
In the experiments described, various protease 
inhibitors were used. Some of these inhibitors, e.g., 
benz~idine, EGTA and~~~y~~eimide, have been 
used in the isolation of procollagen, where rigorous 
inhibition of proteolysis is needed to prevent its 
conversion to collagen (see e.g., [ 121). In addition, 
EGTA should serve to inhibit the Cal’-activated 
muscle protease [131, while ~~thylm~eimide also 
markedfy improves the resolution of the gradients by 
alkylating free sulfhydryls on extraneous proteins in 
the muscle xtracts, which otherwise produce back- 
ground colour by reduction of DTNB. Bacitracin, 
which was used in some experiments, has been 
recommended [14] because of its potent effect in 
preventing degradation of glucagon by microsomal 
extracts. The two other polypeptide inhibitors, leu- 
peptin and pepstatin, in combination, have been shown 
to be very effective in blocking the action of lysoso- 
mal proteases from rat liver, the additional presence of 
an alkylating agent suppressing proteolysis com- 
pletely ]15,16] . It has recently been shown that these 
latter reagents inhibit similarly the lysosomal proteases 
of rat skeletal muscle [ 171. It thus seems most 
probable that extraction in the antiprotease medium 
employed preserves the intrinsic pattern of molecular 
forms of AChE present in intact skeletal muscle. The 
latter conclusion is supported by the results of the 
autolysis experiments shown in fig.lc,d. At 38°C 
both in control and antiprotease extraction media, 
considerable aggregation of AChE occurred. Never- 
theless, in the antiprote~e medium, little degradation 
of the Ha form was observed, nor were the Lr form 
or M forms produced in significant amounts. The 
aggregation phenomenon must therefore result either 
from direct physical aggregation of the L,a species or 
from some other form of enzymic action (e.g., of 
glycosidases orphospholipases). 
Using our protease inhibitor extraction medium, it 
immediately becomes apparent that the only major 
AChE species present in two different fast-twitch 
muscles, pectoral and PLD of the normal chicken, is 
the Hz form. In adult dystrophic hickens large 
amounts of the I+ (6.5 S) form are also observed, 
which are unlikely to be formed from the H form by 
degradation i vitro, but which might be so formed in 
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the dystrophic condition in vivo. Alternatively, this 
elevation of the b form may result from direct over- 
production. In the slow-twitch muscle (ALD), H and 
M forms are present to only a minor extent, Lr and 
L2 forms predominating. Since the H form may com- 
prise as little as 10% total activity, the possibility must 
be considered that it is not the functional species at 
the multiple endplates. It is also detected in small 
amounts in extracts of cardiac muscle, which is devoid 
of conventional endplates. Since it has been demon- 
strated that H forms of AChE are transported down 
the sciatic nerve by rapid axonal flow [ 181, it is pos- 
sible that the Hz AChE detected in ALD and cardiac 
muscle derives from the adhering innervation. 
In the presence of protease inhibitors, a large part 
of the total AChE activity in the rat diaphragm consists 
of L and M forms. However, in the endplate region 
the H form accounts for as much as 40-50% total, 
and this figure might be higher were it possible to 
examine endplates in complete isolation. 
From the above results and discussion it is apparent 
that considerable care must be taken in analysing the 
distribution of AChE forms in muscle (or indeed in 
any tissue) and in assigning functional significance to 
all of the species observed. 
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